Exin opens P45M Philippine hub for AI drug discovery

A P45-million biotechnology investment is bringing artificial intelligence-powered drug discovery to the Philippines, with a new research facility expected to create 35 high-value jobs and develop potential treatments for neurological disorders.

San Francisco-based Exin Therapeutics Inc. has started operating its laboratory in Bonifacio Global City, Taguig, which is designed to develop and validate up to 10 drug candidates a month, the Board of Investments (BOI) said.

The facility, part of Exin’s 2025-to-2027 initial investment phase, will handle research and development, complementing the startup’s computational drug discovery and global business development operations in San Francisco.

The setup puts Filipino scientists and technicians directly into the development of precision genetic therapies and treatments aimed at restoring neural circuits affected by neurological conditions.

Exin is working on potential therapies for epilepsy, autism spectrum disorder and Parkinson’s disease, combining neuroscience, genetics and artificial intelligence to identify promising drug candidates.

The investment brings specialized research work to the country while building local expertise in gene therapy and AI-assisted drug development, fields that could support the expansion of the Philippine biotechnology and pharmaceutical industries.

BOI officials recently visited the facility, about a year after the project secured Green Lane certification in September 2025.

“What is important is seeing a strategic investment move from plans and approvals into actual operations,” said Bobby Fondevilla, executive director of the BOI Investment Assistance Center.

He said the project is creating opportunities for Filipino scientific talent while bringing advanced biotechnology capabilities into the country.

The government facilitated the investment under Executive Order No. 18, which established Green Lanes to fast-track approvals for strategic projects.

Beyond its initial 35 jobs, the facility offers a foothold for the Philippines in a highly specialized segment of drug development, where computing power, genetic research and neuroscience increasingly intersect.

Website | + posts

Related Stories

spot_img

Latest Stories